Platform trial rules out treatments for COVID-19, NIHR Evidence
This research shows that adding doxycycline, azithromycin or colchicine to usual care provides no meaningful benefit to people in the community with COVID-19. They should not be used. Antibiotics should always be used sparingly to prevent bacteria becoming resistant to them. Use of any drug which is not effective puts people at unnecessary risk of side effects, and wastes money. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 18, 2022 Category: Consumer Health News Source Type: news
Amoxicillin (Amoxil) vs. Doxycycline (Vibramycin)
Title: Amoxicillin (Amoxil) vs. Doxycycline (Vibramycin)Category: MedicationsCreated: 5/29/2019 12:00:00 AMLast Editorial Review: 6/29/2022 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 29, 2022 Category: Drugs & Pharmacology Source Type: news
NIHR Alert: Platform trial rules out treatments for COVID-19, NIHR
Expert commentary is provided for a trial which found adding doxycycline, azithromycin or colchicine to usual care provides no benefit to people in the community with COVID-19. These data are useful as preventing ineffective antibiotic use is critical to reduce drug resistance. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 6, 2022 Category: Consumer Health News Source Type: news
Doxycycline Bests Azithromycin for Anogenital Chlamydia in Women
(MedPage Today) -- Doxycycline was superior to azithromycin for women with both anorectal and vaginal Chlamydia trachomatis infections, French researchers found in an open-label randomized trial.
In a modified intention-to-treat analysis, microbiological... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - May 10, 2022 Category: Infectious Diseases Source Type: news
For Pemphigus, Rituximab Is First Line, Expert Says For Pemphigus, Rituximab Is First Line, Expert Says
Lower healthcare costs and efficacy put rituximab ahead of traditional treatments, such as corticosteroids, doxycycline, and immunomodulators, for the autoimmune blistering disease, an expert said.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 1, 2022 Category: Dermatology Tags: Dermatology News Source Type: news
Fluorescence-Guided Debridement of Chronic Osteomyelitis Fluorescence-Guided Debridement of Chronic Osteomyelitis
In this article, the authors describe a technique for fluorescence-guided bone debridement with the preoperative administration of doxycycline.Current Orthopaedic Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 17, 2021 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news
COVID-19 rapid guideline: managing COVID-19 [NG191], NICE (updated 2nd September 2021)
This guideline covers the management of COVID-19 for children, young people and adults in all care settings. It brings together our existing recommendations on managing COVID-19, and new recommendations on therapeutics, so that healthcare staff and those planning and delivering services can find and use them more easily.
We are continually monitoring the evidence and updating the guideline as new information emerges.
On 2 September 2021, we added new recommendations on non-invasive respiratory support and doxycycline, and updated existing recommendations on heparins. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 2, 2021 Category: Consumer Health News Source Type: news
Doxycycline Trumps Azithromycin for Asymptomatic Rectal Chlamydia Doxycycline Trumps Azithromycin for Asymptomatic Rectal Chlamydia
A 1-week course of doxycycline proved to be better than single-dose azithromycin.Medscape Medical News (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - June 30, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news
Common antibiotic found useful in accelerating recovery in tuberculosis patients
(National University of Singapore, Yong Loo Lin School of Medicine) Researchers from NUS Yong Loo Lin School of Medicine's Infectious Diseases Translational Research Programme have discovered that the use of a common antibiotic, doxycycline, in combination with TB drug treatment, reduces the size of lung cavities and accelerates markers of lung recovery. This was done in a trial with 30 pulmonary tberculosis patients. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 19, 2021 Category: Infectious Diseases Source Type: news
Most drugs for treating adult Covid patients not recommended for kids: Government guidelines
About the treatment of children, the guidelines by the Union Health Ministry said most drugs used in adults such as ivermectin, hydroxychloroquine, favipiravir and antibiotics such as doxycycline or azithromycin have not been tested on children for prevention or treatment of Covid infection among them. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 16, 2021 Category: Pharmaceuticals Source Type: news
New studies identify how tuberculosis destroy the lungs and how to protect them
(University of Southampton) A " 3D Culture System " developed by University of Southampton has closely replicated how cells infected with TB change in the human lung. Analytical evidence of these changes identified 7 key gene changes that cause damage in the lungs, from hundreds of thousands. A second trial showed that a common antibiotic, doxycycline, could help reverse these changes and speed up recovery. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 15, 2021 Category: Infectious Diseases Source Type: news
Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomised trial, JMIR
RCT (n=400) found patients with mild-to-moderate COVID-19 infection treated with ivermectin plus doxycycline recovered earlier vs placebo (61% vs 44% with ≤7-day recovery) and were less likely to progress to serious disease and more likely to be negative by RT-PCR on day 14. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 26, 2021 Category: Consumer Health News Source Type: news
Okebo (Doxycycline Monohydrate Capsules) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 26, 2021 Category: Drugs & Pharmacology Source Type: news
Effect of antimicrobial therapy on respiratory hospitalization or death in adults with idiopathic pulmonary fibrosis: The CleanUP-IPF randomized clinical trial
In this pragmatic RCT (n=513) the addition of co-trimoxazole or doxycycline to usual care did not reduce rate of first nonelective respiratory hospitalisation or death (20.4 vs 18.4 events per 100 person-years; p=0.83). (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 13, 2021 Category: Consumer Health News Source Type: news
COVID-19 Therapeutic Alert - Antimicrobials (azithromycin and doxycycline) Not Beneficial in the Management of COVID-19 (SARS-CoV-2) Positive Patients, MHRA
Azithromycin and doxycycline should NOT be used in the management of confirmed or suspected COVID-19 infection within primary care, and azithromycin should not be used in hospitalised patients, unless there are additional indications for which use remains appropriate. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 1, 2021 Category: Consumer Health News Source Type: news
